Resveratrol (trans-3,4′,5-trihydroxystilbene), which has been reported to prevent aggregation and inhibit aggregate toxicity of various amyloid proteins, including transthyretin (TTR), islet amyloid polypeptide (IAPP), α-synuclein and amyloid-β (Aβ-42) peptide [125,126,127,128,129], was shown to inhibit p53 aggregation in a cancer model [67]. Here, TP53 is linked to cancer.